S-Bank Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
S-Bank Fund Management's VRTX Position: Q2 2026 in Review
S-Bank Fund Management increased its Vertex Pharmaceuticals (VRTX) stake by 48% in Q2 2026, buying an estimated $291K and bringing the position to 2,034 shares worth $1.01M. The position accounts for 0.14% of the portfolio, ranked #91.
S-Bank Fund Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.16M in Q1 2025. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- S-Bank Fund Management held 2,034 shares of Vertex Pharmaceuticals worth $1.01M as of Q2 2026.
- S-Bank Fund Management bought 657 Vertex Pharmaceuticals shares in Q2 2026, an estimated $291K.
- Vertex Pharmaceuticals made up 0.14% of S-Bank Fund Management's portfolio in Q2 2026, its #91 holding.
- S-Bank Fund Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- S-Bank Fund Management's Vertex Pharmaceuticals position peaked at $1.16M in Q1 2025.
- 1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.